What is the appropriate aripiprazole dose for a 60-year-old patient, and can it cause hyponatremia?

Aripiprazole Dosing and Hyponatremia Risk in a 60-Year-Old

For a 60-year-old patient, start aripiprazole at 10-15 mg daily, and yes, aripiprazole can cause hyponatremia, though the risk appears lower than with many other antipsychotics.

Appropriate Dosing

The FDA-approved starting and target dose for aripiprazole is 10 or 15 mg once daily, administered without regard to meals 1. The therapeutic range extends from 10-30 mg/day, though doses higher than 10-15 mg/day have not demonstrated superior efficacy 1.

Key dosing principles:

• Allow at least 2 weeks between dose increases to reach steady-state concentrations 1
• Full therapeutic effect may take 1-4 weeks to manifest 2
• The optimal dose based on clinical trial data is 10 mg/day, with the highest response rates seen at this dose 3
• Doses above 20 mg/day provide no additional benefit and may actually result in smaller symptom improvements 3

For a 60-year-old without specific metabolic considerations, initiate at 10-15 mg daily and maintain at this dose for at least 4 weeks before considering any adjustment 4. The 2025 INTEGRATE guidelines support aripiprazole as a suitable option for both first-line treatment and for switching when addressing negative symptoms 4.

Hyponatremia Risk

Aripiprazole CAN cause hyponatremia through SIADH (syndrome of inappropriate antidiuretic hormone secretion), but the risk is significantly lower compared to other antipsychotics, particularly olanzapine 5.

Evidence of Risk:

The most recent and highest-quality evidence comes from a 2026 comparative study analyzing 961,010 patients, which found that aripiprazole was associated with a 48% lower risk of hyponatremia compared to olanzapine (adjusted hazard ratio 0.52,95% CI 0.35-0.76) 5. This makes aripiprazole one of the safer antipsychotic choices for patients at risk of electrolyte disturbances.

However, case reports document that aripiprazole-induced hyponatremia does occur:

• A 65-year-old developed severe hyponatremia (sodium 108 meq/L) after aripiprazole dose increase from 10 to 20 mg, with recurrence upon rechallenge 6
• A 50-year-old developed hyponatremia within 3 days of aripiprazole initiation 7
• Multiple case reports confirm SIADH as the mechanism 8, 9

Clinical Implications:

Monitor sodium levels in the following scenarios:

• Baseline measurement before initiating aripiprazole (part of standard antipsychotic monitoring) 4
• Within the first 2-4 weeks after initiation or dose increase, when risk is highest 10
• Any patient presenting with confusion, nausea, vomiting, headache, or dizziness while on aripiprazole 6
• Elderly patients or those on concurrent medications that increase hyponatremia risk (thiazides, SSRIs, carbamazepine) 10

Important caveat: While aripiprazole's hyponatremia risk is lower than many alternatives, it is NOT zero. The rapid onset (within days) and severity (sodium as low as 108 meq/L) documented in case reports means clinicians cannot be complacent 6, 7. For a 60-year-old, age itself increases vulnerability to electrolyte disturbances.

Management if Hyponatremia Develops:

• Discontinue aripiprazole immediately 6
• Implement fluid restriction
• Do NOT rechallenge with aripiprazole if severe hyponatremia occurred 6, 9
• Consider switching to an alternative antipsychotic with even lower hyponatremia risk if needed

Bottom line: Aripiprazole at 10-15 mg daily is appropriate for a 60-year-old, with lower hyponatremia risk than most antipsychotics, but baseline and early monitoring of sodium is essential given documented cases of severe SIADH.